MeSH term | MeSH ID | Detail |
---|---|---|
Diabetes Mellitus, Experimental | D003921 | 85 associated lipids |
Body Weight | D001835 | 333 associated lipids |
Dermatitis, Atopic | D003876 | 19 associated lipids |
Eriodictyol is a lipid of Polyketides (PK) class. Eriodictyol is associated with abnormalities such as Hyperostosis, Diffuse Idiopathic Skeletal, Macular degeneration, Consumption-archaic term for TB, Retinal Diseases and PARAGANGLIOMAS 4. The involved functions are known as glutathione biosynthetic process, Cytoprotection, Oxidants, protein expression and Cell Survival. Eriodictyol often locates in Cytoplasmic matrix, Protoplasm, Cytoplasmic, Cell Fraction and Back. The associated genes with Eriodictyol are NQO, HMOX1 gene, IMPACT gene, RPS6KA3 gene and GDNF gene.
To understand associated biological information of ERIODICTYOL, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
ERIODICTYOL is suspected in Macular degeneration, Retinal Diseases, PARAGANGLIOMAS 4 and other diseases in descending order of the highest number of associated sentences.
Disease | Cross reference | Weighted score | Related literature |
---|
We collected disease MeSH terms mapped to the references associated with ERIODICTYOL
MeSH term | MeSH ID | Detail |
---|---|---|
Diabetes Mellitus, Experimental | D003921 | 85 associated lipids |
Body Weight | D001835 | 333 associated lipids |
Dermatitis, Atopic | D003876 | 19 associated lipids |
There are no associated biomedical information in the current reference collection.
Associated locations are in red color. Not associated locations are in black.
Location | Cross reference | Weighted score | Related literatures |
---|
Function | Cross reference | Weighted score | Related literatures |
---|
Lipid concept | Cross reference | Weighted score | Related literatures |
---|
Gene | Cross reference | Weighted score | Related literatures |
---|
There are no associated biomedical information in the current reference collection.
Authors | Title | Published | Journal | PubMed Link |
---|---|---|---|---|
Guo X et al. | Separation of the enantiomers of naringenin and eriodictyol by amylose-based chiral reversed-phase high-performance liquid chromatography. | 2012 | Drug Discov Ther | pmid:23337820 |
Kizaibek M et al. | Towards modernization of the formulation of the traditional uighur medicine herbal preparation abnormal savda munziq. | 2012 | Evid Based Complement Alternat Med | pmid:21837249 |
Lou H et al. | Eriodictyol protects against H(2)O(2)-induced neuron-like PC12 cell death through activation of Nrf2/ARE signaling pathway. | 2012 | Neurochem. Int. | pmid:22609376 |
Zhang WY et al. | Effect of eriodictyol on glucose uptake and insulin resistance in vitro. | 2012 | J. Agric. Food Chem. | pmid:22809065 |
Yoo JM et al. | Inhibitory effect of eriodictyol on IgE/Ag-induced type I hypersensitivity. | 2012 | Biosci. Biotechnol. Biochem. | pmid:22785465 |
Hu YF and Wu CC | [Chemical constituents from stems of Lonicera macranthoides]. | 2012 | Zhong Yao Cai | pmid:22734414 |
Bucolo C et al. | Eriodictyol prevents early retinal and plasma abnormalities in streptozotocin-induced diabetic rats. | 2012 | Biochem. Pharmacol. | pmid:22484312 |
Hu Q et al. | Eriodictyol-7-O-glucoside, a novel Nrf2 activator, confers protection against cisplatin-induced toxicity. | 2012 | Food Chem. Toxicol. | pmid:22465804 |
Habtemariam S | The anti-obesity potential of sigmoidin A. | 2012 | Pharm Biol | pmid:22978690 |
Freischmidt A et al. | Contribution of flavonoids and catechol to the reduction of ICAM-1 expression in endothelial cells by a standardised Willow bark extract. | 2012 | Phytomedicine | pmid:21982436 |